Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MUSE: clinical experience.

M A Khan1, M Raistrick, D P Mikhailidis

  • 1Department of Urology, Royal Free and University College Medical School (University College London), The Royal Free Hampstead NHS Trust, UK. Ktasmas@aol.com

Current Medical Research and Opinion
|May 23, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endocrine Disorders and Peripheral Arterial Disease - A Series of Reviews Cushing Syndrome-Cortisol Excess.

Current vascular pharmacology·2023
Same author

Growth Hormone, Atherosclerosis and Peripheral Arterial Disease: Exploring the Spectrum from Acromegaly to Growth Hormone Deficiency.

Current vascular pharmacology·2023
Same author

Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis.

Digestive diseases and sciences·2021
Same author

Multifocal arterial disease: clinical implications and management.

Current opinion in cardiology·2020
Same author

Preface.

Current vascular pharmacology·2018
Same author

Daylight saving time and myocardial infarction: should we be worried? A review of the evidence.

European review for medical and pharmacological sciences·2018

Medication for Erectile Dysfunction (ED) using MUSE (intra-urethral alprostadil) showed moderate effectiveness. High dropout rates due to inefficacy and side effects necessitate close patient follow-up.

Area of Science:

  • Urology
  • Andrology
  • Pharmacology

Background:

  • Erectile dysfunction (ED) affects a significant percentage of men in the UK.
  • Intracavernosal injections were a primary treatment for ED before sildenafil.
  • Medication urethral system for erection (MUSE) offers a needle-free alternative for alprostadil administration.

Purpose of the Study:

  • To investigate the safety and efficacy of MUSE for treating erectile dysfunction.
  • To assess patient adherence and satisfaction with MUSE over a six-month period.

Main Methods:

  • One hundred patients diagnosed with ED were initiated on MUSE treatment.
  • Patients were trained in self-administration before discharge.
  • A follow-up questionnaire was administered after six months to assess outcomes.

Related Experiment Videos

Main Results:

  • Initial successful treatment with MUSE was achieved in only 35% of patients.
  • After six months, only 43% of initially successful patients continued MUSE use.
  • Common reasons for discontinuation included reduced efficacy and side effects like urethral bleeding and irritation.

Conclusions:

  • MUSE demonstrates moderate effectiveness as an ED treatment option.
  • It serves as an alternative for patients unresponsive to or contraindicated for other ED therapies.
  • Close patient monitoring is recommended due to high dropout rates.